{
    "id": 17855,
    "fullName": "SMO S533N",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SMO S533N lies within transmembrane domain 7 of the Smo protein (UniProt.org). S533N (corresponding to S539N in mouse) has been demonstrated to confer resistance to Hedgehog (Hh) pathway inhibitors (PMID: 26546616, PMID: 9581815), and results in increased Hh pathway activation in mouse models and human tumor samples (PMID: 10984056, PMID: 9581815), but also results in similar cell proliferation and viability levels as compared to wild-type Smo in cell culture (PMID: 29533785), and therefore, its effect on Smo protein function is unknown.",
            "references": [
                {
                    "id": 1301,
                    "pubMedId": 10984056,
                    "title": "Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10984056"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 1940,
                    "pubMedId": 9581815,
                    "title": "Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9581815"
                },
                {
                    "id": 4477,
                    "pubMedId": 26546616,
                    "title": "An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26546616"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6608,
        "geneSymbol": "SMO",
        "terms": [
            "SMO",
            "CRJS",
            "FZD11",
            "Gx",
            "SMOH"
        ]
    },
    "variant": "S533N",
    "createDate": "02/11/2016",
    "updateDate": "04/02/2020",
    "referenceTranscriptCoordinates": {
        "id": 123229,
        "transcript": "NM_005631",
        "gDna": "chr7:g.129210494G>A",
        "cDna": "c.1598G>A",
        "protein": "p.S533N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4454,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In an open-label clinical trial, treatment with Sonidegib (LDE225) resulted in progressive disease in a basal cell carcinoma patient with resistance to Erivedge (vismodegib) harboring SMO D533N (PMID: 26546616).",
            "molecularProfile": {
                "id": 18162,
                "profileName": "SMO S533N"
            },
            "therapy": {
                "id": 1428,
                "therapyName": "Sonidegib",
                "synonyms": null
            },
            "indication": {
                "id": 2513,
                "name": "basal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4477,
                    "pubMedId": 26546616,
                    "title": "An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26546616"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18162,
            "profileName": "SMO S533N",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 123229,
            "transcript": "NM_005631",
            "gDna": "chr7:g.129210494G>A",
            "cDna": "c.1598G>A",
            "protein": "p.S533N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}